Table 2.
Effect of oral administration of AFB1 alone or in combination with Q and/or CNPs on serum cytokines, procollagen III and nitric oxide.
Parameter groups | CEA (ng/ml) | TNF-α (ng/l) | IL-1α (ng/ml) | Procollagen III (μg/l) | NO (μmol/l) |
---|---|---|---|---|---|
Control | 2.75 ± 0.34a | 57.3 ± 2.95 a | 0.75 ± 0.03a | 2.6 ± 0.12a | 34.74 ± 1.93a |
AFB1 | 9.54 ± 1.51b | 96.42 ± 2.33b | 4.24 ± 0.93b | 8.96 ± 0.86b | 85.83 ± 2.44b |
CNPs-LD | 2.55 ± 0.62a | 55.23 ± 2.63a | 0.74 ± 0.02a | 2.55 ± 0.21a | 33.86 ± 2.45a |
CNPs-HD | 2.66 ± 0.52a | 56.72 ± 2.47a | 0.77 ± 0.04a | 2.59 ± 0.23a | 34.62 ± 2.09a |
Q | 2.71 ± 0.33a | 57.22 ± 2.62a | 0.76 ± 0.04a | 2.89 ± 0.31a | 35.64 ± 1.88a |
CNPs-LD + Q | 2.77 ± 0.37a | 56.92 ± 1.94a | 0.77 ± 0.05a | 2.49 ± 0.47a | 35.43 ± 2.53a |
CNPs-HD + Q | 2.79 ± 0.64a | 58.1 ± 3.42a | 0.77 ± 0.07a | 2.58 ± 0.41a | 35.82 ± 2.94a |
CNPs-LD + AFB1 | 4.93 ± 0.86c | 67.53 ± 3.63c | 2.99 ± 0.75c | 5.74 ± 1.22d | 57.83 ± 2.44c |
CNPs-HD + AFB1 | 4.22 ± 0.77c | 62.75 ± 2.96d | 2.53 ± 0.84c | 4.96 ± 1.31d | 55.83 ± 2.48c |
Q + AFB1 | 4.76 ± 1.22c | 64.83 ± 2.67e | 2.67 ± 0.45c | 4.99 ± 1.08d | 59.84 ± 2.45c |
CNPs-LD + Q + AFB1 | 3.95 ± 0.93d | 60.42 ± 1.69d | 1.87 ± 0.54e | 3.83 ± 0.89e | 43.82 ± 2.94d |
CNPs-HD + Q + AFB1 | 2.83 ± 0.92a | 58.52 ± 2.66a | 1.22 ± 0.23e | 2.83 ± 0.77a | 38.32 ± 2.76e |
Within each column, means superscript with different letters are significantly different (P ≤ 0.05).